• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medpace Hires Executive to Open Bioanalytical Lab in Fall

Medpace Hires Executive to Open Bioanalytical Lab in Fall

August 5, 2008
CenterWatch Staff

Cincinnati-based Medpace, a global contract research organization (CRO), has hired Yong-Xi Li as Executive Director of its new Medpace Bioanalytical Laboratories. This new laboratory is projected to open in fall of 2008 and will complement services provided by other Medpace research facilities, such as Medpace Clinical Pharmacology and Medpace Reference Laboratories.

Dr. Li joins Medpace with a strong background in bioanalytical technology, method development, validation, and sample analysis in support of pharmaceutical development and both preclinical and clinical studies.

At Medpace, Dr. Li will direct operations and activities of the new, advanced mass spectrometry Medpace Bioanalytical Laboratories, including bioanalytical aspects for small and large drug molecules according to GLP and GMP compliances and ICH guidelines.

Dr. Li comes to Medpace from Eurofins Scientific, NJ, where he served as Senior Director, managing its laboratory process and facilitating bioanalytical technology and methods. Prior to his work at Eurofins Scientific, Dr. Li was the Vice President of Ricerca and then the Vice President of XenoBiotic Laboratories, where he led and expanded the bioanalytical laboratories and activities.

Dr. Li arrived in the United States and worked as a senior research scientist under Dr. K.J. Klubende and Dr. B.H. Davis to establish his first bioanalytical laboratory. He went on to do postdoctoral studies in Chemistry at Cornell University, Baker Laboratory, in Ithaca, New York.

“We are excited to have an experienced chemist such as Yong-Xi Li on staff,” said August Troendle, M.D., Medpace’s CEO.

Upcoming Events

  • 12Apr

    The Participant Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing